Attana’s presentation from Småbolagsdagarna is now available on YouTube

Report this content

On June 14, Attana attended Aktiespararna’s Småbolagsdagarna where CEO, Teodor Aastrup, gave a 20-minute-long presentation followed by a 10-minute-long Q&A.

The presentation was held in Swedish and primarily focused on Attana’s history and milestones, followed by Attana’s ongoing work within both its business areas – Life Science and Diagnostics. The presentation concluded with Attana long-term, 2030 plan.

The presentation can be accessed by following this link:

Attana – Småbolagsdagarna 2022

For more information, please contact:

Teodor Aastrup, CEO
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit or contact



Documents & Links